Research and Markets: Single Use Bioreactor Market by Product Type, Cell Type, Technology, End User - Global Forecast to 2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kx9sqp/single_use) has announced the addition of the "Single Use Bioreactor Market by Product Type, Cell Type, Technology, End User - Global Forecast to 2019" report to their offering.

The single use bioreactors (SUBs) market is expected to grow at a double digit CAGR of 18.4% to reach $470.9 million by 2019 from $202.5 million in 2014.

Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

This report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion's share of the global SUB market, by molecule type. However, the stem cell segment is expected to grow at the highest CAGR in the forecast period, owing to an increased focus on research in this segment.

On the basis of type of cell, the SUB market is categorized into mammalian cell, bacterial cell, yeast cell and others (insect cell and plant cell). The mammalian cell segment is expected to be the new revenue pocket in the market by type of cell. Increasing numbers of biologics are being based on mammalian cells due to their increased compatibility and bioactivity in humans.

The technology segment is subsegmented into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors and others (single-use reactors with vertically perforated discs and single-use hybrid reactors). Wave-induced motion SUB technology is the oldest and most widely accepted of these, which accounts for its large market share.

Research and development (R&D) of biopharmaceutical manufacturers, research institutes and contract research organizations (CROs) are the major end users of the SUB, followed by biopharmaceutical manufacturing. The large share of the R&D segment can be attributed to the wide acceptance of SUBs for small- and mid-scale biopharmaceutical manufacturing for clinical testing and R&D. New and innovative product launches were found to be the dominant strategy adopted by key industry participants to increase their market share and cater to unmet market needs.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Single Use Bioreactor Market, By Technology

8 Single Use Bioreactor Market, By Molecule Type

9 Single Use Bioreactor Market, By Type Of Cell

10 Single Use Bioreactor Market, By End User

11 Single Use Bioreactor Market, By Geography

12 Competitive Landscape

13 Company Profiles

- Applikon Biotechnology

- Cellexus Limited

- Cellution Biotech

- GE Healthcare (Subsidiary Of General Electric Company)

- Merck Kgaa

- Pall Corporation

- Parker Hannifin Corporation

- Pbs Biotech, Inc.

- Sartorius Ag

- Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/kx9sqp/single_use

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology